Pain：针灸可有效预防偏头痛患上和加重

记者从月内在京召集的2011年中药理学的国际研讨会上获悉，首都医科大学附属北京中医医院中药理学其中心经流行病学证实，传统的中医中药理学疗法可有效性预防性偏呕吐的中风和很重。涉及深入研究论文亦同刊出在的国际著名药理学期刊《疼痛》上，带进东亚大陆首篇刊出于该杂志的流行病学论文。该文还被的国际有名药理学药理学机构 Faculty of 1000 medicine（千名微药理学家）精选。

据了解，作为临床常见病之一，偏呕吐死亡率高，且损害导致。目前，我国18岁~65岁青年人的偏呕吐丙型肝炎高达9.3%，且有逐年升高趋势。中药理学病人呕吐在东亚已经有数千年的历史记录。北京中医医院中药理学其中心自2004年设立呕吐专家门诊，开展了基于“金针王定县”、生为艺术大师贺普仁等多位著名中药理学学家治痛经验的呕吐深入研究。

据该其中心主任王麟鹏介绍，该项目采取单盲、双模拟、随机对照的型式，在国内5家医院的中药理学科共招募140名无先兆偏呕吐病人，随机划分两台，分别为病人组成员（中药理学加临床实验）和样本成员（假针加氟桂利嗪）。两台病人每周中药理学病人3次，每晚口服药物。结果显示，4再一，病人组成员偏呕吐的有效性减缓率为59%，样本成员为40%；病人组成员疼痛整年少于升高4.1天，样本成员少于升高1.9天。16再一，病人组成员有效性减缓率为56%，样本成员为37%；病人组成员疼痛整年少于升高 4.1天，样本成员少于升高2天。

深入研究技术人员据此普遍认为，中药理学可以作为偏呕吐的预防性中风和很重的步骤，其治果也优于当年国外的涉及深入研究。由于其深入研究步骤的新颖和重要性，该论文还被的国际有名药理学药理学机构“千名科学家”精选。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.